Krebs Biochemicals and Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

KREBSBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.3%1-day move

₹57.15

prior close

₹68.58

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.0-0.3-0.2+7.2+8.3+8.5+9.2+5.0+8.5+17.2+2.9

Up moveDown movePending

AI summary

Krebs Biochemicals and Industries Limited has submitted a compliance certificate to BSE and NSE under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate, covering the quarter ended March 31, 2026, was issued by KFIN Technologies Limited, the company's Registrar and Share Transfer Agent. It confirms that details of shares dematerialised and rematerialised during the quarter have been furnished to both NSDL and CDSL as well as the stock exchanges where the company is listed. This is a routine regulatory filing with no disclosed transaction data or financial figures.

Likely market impact

This is a standard quarterly compliance disclosure with no business or financial impact. It does not affect share price or shareholder value; it merely fulfils a routine SEBI reporting requirement.